Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need

By LabMedica International staff writers
Posted on 07 Sep 2022

When the requirement is for infectious disease testing, every minute counts to inform treatment decisions and slow the risk of transmission. More...

Having rapid multiplex PCR testing at the point of need can make life better for millions of people in hospitals, clinics, airports, care homes, events, workplaces, and a wider variety of other settings. Now, a portable and simple to use rapid multiplex PCR testing system delivers fast, accurate and actionable results in approximately 30 minutes at the point of need.

The Q-POC platform from QuantuMDx Group Ltd. (Tyne and Wear, UK) compresses an entire molecular diagnosis laboratory into a simple-to-use, accessible and portable single device that produces results in approximately 30 minutes. The many innovative features incorporated into the Q-POC platform make it a safe rapid multiplex PCR testing solution for all clinical environments. With the Q-POC supercharged platform, it is no longer necessary to wait hours or days for test results.

The Q-POCT platform has been engineered to limit the need for highly skilled operators and offer a smooth user experience behind each interaction with its intuitive interface. The software is designed with the simplicity and familiarity of smartphone and tablet interfaces. It requires only three minutes hands-on-time to get each test started, using easy to follow, guided workflows on the touch screen. A ready to use solution, with all its simplicity, accuracy and speed, the Q-POCT requires no calibration or preventive maintenance. Each test cassette contains all the necessary reagents to complete a test and can be stored and shipped at room temperature. Users can just load the cassette and press go.

A ton of tech is behind every result, with intelligent multilingual software algorithms integrated into the Q-POCT platform. Clear, simple test results are automatically generated by sophisticated software algorithms, removing any complicated interpretation of the result. The Q-POCT software has been designed with the user in mind and uses intuitive, user centric software design similar to a smartphone allowing clear and easy reporting. The small, portable, battery-operated Q-POCT system marks a huge leap in rapid multiplex PCR testing. Its compact design, as well as its internal lithium-ion battery, supports use in a wide variety of clinical settings, at the Point of Need.

Related Links:
QuantuMDx Group Ltd. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.